Trial intelligence / Profile preview

Safety and Consistency of Post-marketing EV71 Vaccine in Children

NCT02889497Phase 4Unknown

Sponsor
Beijing Chaoyang District Center for Disease Control and Prevention
Start
Sep 2016
Primary completion
Mar 2019
Modality
Vaccines & Immunotherapeutics
01

Overview

A Phase 4 trial of enterovirus 71 vaccine (vero cell), inactivated in HIV-associated central nervous system involvement (HAND), sponsored by Beijing Chaoyang District Center for Disease Control and Prevention. Status: unknown.

02

Drugs

enterovirus 71 vaccine (vero cell), inactivated
03

Conditions

HIV-associated central nervous system involvement (HAND)

Beyond the preview

Go deeper on NCT02889497.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02889497.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call